Correlation Between Entegris and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entegris and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entegris and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entegris and BioNTech SE, you can compare the effects of market volatilities on Entegris and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entegris with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entegris and BioNTech.

Diversification Opportunities for Entegris and BioNTech

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Entegris and BioNTech is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Entegris and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Entegris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entegris are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Entegris i.e., Entegris and BioNTech go up and down completely randomly.

Pair Corralation between Entegris and BioNTech

Given the investment horizon of 90 days Entegris is expected to under-perform the BioNTech. But the stock apears to be less risky and, when comparing its historical volatility, Entegris is 1.32 times less risky than BioNTech. The stock trades about -0.03 of its potential returns per unit of risk. The BioNTech SE is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  10,873  in BioNTech SE on October 11, 2024 and sell it today you would earn a total of  1,342  from holding BioNTech SE or generate 12.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Entegris  vs.  BioNTech SE

 Performance 
       Timeline  
Entegris 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Entegris has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
BioNTech SE 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, BioNTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Entegris and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entegris and BioNTech

The main advantage of trading using opposite Entegris and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entegris position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Entegris and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum